+499.5%
MRNA vs INVH
-2.4%
+501.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | INVH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.2% | -2.0% | -2.1% |
| 7D | +5.5% | -2.9% | +8.4% | +7.9% |
| 30D | +158.7% | -6.9% | +165.7% | +170.4% |
| 3M | +182.1% | -2.7% | +184.8% | +192.9% |
| 6M | +151.8% | +8.2% | +143.6% | +152.1% |
| YTD | +393.6% | +4.5% | +389.1% | +403.1% |
| 1Y | +499.5% | -2.3% | +501.8% | +531.2% |
| All | +499.5% | -2.4% | +501.8% | +531.2% |
Cumulative growth
Daily Returns
Daily percentage return beside INVH.
Daily Out/Under-Performance
Portfolio return minus INVH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INVH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded INVH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling